Shankar Ramaswamy, MD, is Chief Business Officer at Axovant. He is responsible for the identification, evaluation, and negotiation of transactions for new gene therapy pipeline assets and other business development opportunities. He has served the company in multiple roles including, most recently, Senior Vice President of Business Development and Operations and previously, Vice President of Global Medical Affairs. Dr. Ramaswamy received a M.D. from Brown University and an A.B. in economics from Harvard University.